Review Article

Comparison of Amino Acid PET to Advanced and Emerging MRI Techniques for Neurooncology Imaging: A Systematic Review of the Recent Studies

Table 3

Summary of aaPET with MRS studies.

StudyYearStudy locationNo. of patientsaaPETMRSTumor typeMain results

Kudulaiti et al. [63]2019Shanghai, China109METCNINonenhancing supratentorial gliomaMET PET was more sensitive and specific than MRS, and when combined, sensitivity was higher and specificity stable.
Kebir et al. [64]2019Essen, Germany19METNAA, Cho, CrNewly diagnosed gliomaBoth have limited potential in glioma subtyping. MET PET is better for differentiating IDH status and MRS for glioma subgrouping.
Lundemann et al. [49]2019Copenhagen, Denmark16FET3D MRSIGlioblastomaFET PET had the highest predictive value for recurrence. 3D MRSI was of insufficient quality for analysis.
Verburg et al. [52]2020Amsterdam, Netherlands20FETCNINewly diagnosed nonenhancing gliomaFET PET combined with other modalities detects glioma infiltration better than standard MRI or FET PET. MRS data is insufficient due to limited sampling ability.
Piccardo et al. [54]2019Genoa, Italy22FDOPACNI, Cho/Cr, lactatePediatric DMGBoth could differentiate tumor grade and H3K27M mutation, but only FDOPA PET could do so independently of histology.

Cho: choline; Cr: creatine; CNI: choline-to-N-acetylaspartate index; NAA: N-acetylaspartate.